SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-21-000969
Filing Date
2021-03-16
Accepted
2021-03-16 17:13:09
Documents
84
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT xenetic_10k-123120.htm 10-K 1123391
2 CERTIFICATE OF AMENDMENT xenetic_ex0312.htm EX-3.12 19476
3 CERTIFICATE OF AMENDMENT xenetic_ex0313.htm EX-3.13 19510
4 DESCRIPTION OF THE REGISTRANT S SECURITIES xenetic_ex0401.htm EX-4.1 23796
5 SUBSIDIARIES OF REGISTRANT xenetic_ex2101.htm EX-21.1 3215
6 INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM CONSENT xenetic_ex2301.htm EX-23.1 2174
7 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER xenetic_ex3101.htm EX-31.1 10331
8 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER xenetic_ex3102.htm EX-31.2 10332
9 CERTIFICATION xenetic_ex3201.htm EX-32.1 5290
10 GRAPHIC ex0312_image1.jpg GRAPHIC 78698
11 GRAPHIC ex0312_image2.jpg GRAPHIC 53822
12 GRAPHIC ex0313_image1.jpg GRAPHIC 88148
13 GRAPHIC ex0313_image2.jpg GRAPHIC 60945
  Complete submission text file 0001683168-21-000969.txt   5392645

Data Files

Seq Description Document Type Size
14 XBRL INSTANCE FILE xbio-20201231.xml EX-101.INS 728187
15 XBRL SCHEMA FILE xbio-20201231.xsd EX-101.SCH 50734
16 XBRL CALCULATION FILE xbio-20201231_cal.xml EX-101.CAL 56570
17 XBRL DEFINITION FILE xbio-20201231_def.xml EX-101.DEF 278315
18 XBRL LABEL FILE xbio-20201231_lab.xml EX-101.LAB 367218
19 XBRL PRESENTATION FILE xbio-20201231_pre.xml EX-101.PRE 349167
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37937 | Film No.: 21746931
SIC: 2834 Pharmaceutical Preparations